A 21-marker blood panel that checks kidney function, liver function, cholesterol, blood sugar (HbA1c) and pancreas health, aimed at people taking the GLP-1 medication Dulaglutide (Trulicity). Suits ongoing monitoring rather than a first general health check.
21 biomarkers as listed by Blue Horizon Medicals.
This panel brings together 21 markers used to monitor several body systems while you're taking Dulaglutide (Trulicity), a long-acting GLP-1 medication used to manage type 2 diabetes. It covers kidney function (sodium, urea, chloride, eGFR, creatinine), liver function (total protein, albumin, globulin, ALP, ALT, AST, GGT, bilirubin), a lipid profile (cholesterol, triglycerides, HDL, HDL%, LDL, non-HDL), HbA1c for longer-term blood sugar, and lipase, which is commonly used to assess pancreas health.
We don't currently track directly comparable tests for this specific use case, so there's no named peer to weigh it against. Its 21 biomarkers put it well above the typical size for the metabolism and weight tests we do track, and at £129.75 it sits close to the usual price for a panel of that size.
It scores well for clinical depth given its marker count, and for documentation, since the listing sets out the full biomarker list, sample type, collection options and turnaround clearly, though not what the report itself looks like. It scores lower for collection convenience because it needs a venous draw at a clinic or a home nurse visit, and turnaround is 5 days rather than 1. Results are reviewed by a doctor, and Blue Horizon has traded since 2009 with a Trustpilot score of 4.2 from 395 reviews, using UKAS ISO 15189 partner labs.
This suits people already prescribed Dulaglutide (Trulicity) who want a periodic check on kidney function, liver function, cholesterol, blood sugar and pancreas health while on treatment. The provider suggests a baseline test before starting and a re-check roughly every three months or after a dose change.
It isn't intended as a general health check for people not on this medication, and it isn't a substitute for reporting new symptoms to your GP. We don't have a directly comparable test from another provider in our tracked catalogue to suggest as a cheaper or broader alternative.
This is a venous blood test taken at a Blue Horizon clinic or by a home nurse visit. Your sample is sent to the lab for kidney, liver, lipid, HbA1c and lipase analysis, with results back in around 5 days. A doctor reviews the results before you receive them.
A 21-marker panel priced at £129.75, aimed at people on the GLP-1 medication Dulaglutide (Trulicity), covering kidney and liver function, a lipid profile, HbA1c and lipase. We don't track a directly comparable test to weigh it against on price, but its marker count is well above the typical metabolism panel size. Turnaround is longer than many tests here, at 5 days, and there's no at-home collection option.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
21 biomarkers, placing it in the 78th percentile of metabolism tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, in line with or faster than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£129.75 against a median of £124.38 for the 14 similarly sized metabolism tests we track (+4%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Mid-depth metabolic panel priced well below peers
Measures 19 markers of blood sugar, cholesterol, liver, kidney and inflammation to give a broad view of metabolic health.
Below-median price for a single-marker uric acid test
A single-marker blood test measuring uric acid, used to help monitor gout risk and related joint, kidney and metabolic health.
Broad 21-marker panel for people on oral semaglutide
A 21-marker blood panel covering kidney, liver, lipid and blood sugar markers plus lipase, aimed at people taking oral semaglutide (Rybelsus) who want to monitor how their body is responding over time.
21-marker organ and metabolic check for Tirzepatide users
This 21-marker panel checks liver, kidney, lipid and blood sugar markers alongside lipase, aimed at people taking Tirzepatide (sold as Mounjaro or Zepbound) who want to monitor how their body is responding to the medication.
